← Browse by Condition
Medical Condition

respiratory syncytial virus infections

Total Trials
5
Recruiting Now
5
Trial Phases
Phase 3, Phase 1
NCT06593210 Phase 3
Recruiting

RSV Vaccine in Transplant Recipients

Enrollment
100 pts
Location
Canada
Sponsor
University Health Network, Tor...
View Trial →
NCT07220109 Phase 3
Recruiting

A Study on the Immune Response and Safety of Vaccine Against Respiratory Syncytial Virus Given to Chinese Adults 18 to 59 Years of Age at Increased Risk of Respiratory Syncytial Virus Disease

Enrollment
750 pts
Location
China
Sponsor
GlaxoSmithKline
View Trial →
NCT06645665 Phase 1
Recruiting

A Study to Describe the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine IN006 in Healthy Adult Aged 18 Years and Above

Enrollment
240 pts
Location
China
Sponsor
Shenzhen Shenxin Biotechnology...
View Trial →
NCT07239583
Recruiting

Genotype and Disease Burden of RSV in Older Vietnamese Adults (RSV: Respiratory Syncytial Virus )

Enrollment
1,000 pts
Location
Vietnam
Sponsor
Tam Anh Research Institute
View Trial →
NCT06363370 Phase 3
Recruiting

Human Interferon α1b Inhalation Solution Against Respiratory Syncytial Virus in Children With Lower Respiratory Tract Infections

Enrollment
322 pts
Location
China
Sponsor
Kexing Biopharm Co., Ltd.
View Trial →